Lv7
4010 积分 2023-04-20 加入
Stapokibart: First Approval
21小时前
待确认
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
2天前
已完结
COPD and biologic treatment: state of the art
2天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
3天前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
3天前
已关闭
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
3天前
已关闭
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
3天前
已关闭
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
3天前
已完结
Use of long-acting injectable cabotegravir/rilpivirine in people with HIV and adherence challenges
2个月前
已完结
Chronic obstructive pulmonary disease
2个月前
已完结
皖公网安备34019202002308
